Amount Raised
$45 Million
Round Type
Series C
Mountain ViewBiotechnologyHealth CareInvestors
Description
Alto Neuroscience, Inc. today announced an oversubscribed $45 million Series C financing. The round was led by InVivium Capital, with participation from additional new investors Franklin Templeton, Point72, Eli Lilly and Company, and Alexandria Venture Investments. Existing investors Alpha Wave Ventures, Lightswitch Capital, partners of Alkeon Capital, WhatIf Ventures, and Windham Venture Partners also participated in the financing.
Quick answer
Alto Neuroscience raised $45 Million in a Series C round, dated November 21, 2023. Investors: Alexandria Venture Investments, Franklin Templeton, Point72, Eli Lilly And Company, Alpha Wave Ventures, Lightswitch Capital, Alkeon Capital and What If Ventures. Alto Neuroscience is based in Mountain View, California, United States.
- How much did Alto Neuroscience raise?
- Alto Neuroscience raised $45 Million in a Series C round on November 21, 2023.
- Who invested in Alto Neuroscience?
- Alexandria Venture Investments, Franklin Templeton, Point72, Eli Lilly And Company, Alpha Wave Ventures, Lightswitch Capital, Alkeon Capital and What If Ventures are named as investors in this round.
- What does Alto Neuroscience do?
- Alto Neuroscience is a biopharmaceutical company redefining psychiatry through its Precision Psychiatry Platform™, which leverages individuals’ neurobiology to develop personalized and highly effective medicines that..
- Where is Alto Neuroscience based and how big is it?
- Alto Neuroscience is based in Mountain View, California, United States. Fundz records about 76 employees.
- Who are the decision-makers at Alto Neuroscience?
- Fundz holds 2 contacts at Alto Neuroscience, including the VP of Translational Medicine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Alto Neuroscience that raised within 45 days of this round, from Fundz verified event records.
- Clarametyx Biosciences raised $33M (Series A) on January 5, 2024.
- Clarametyx Biosciences raised $28M on January 5, 2024.
- Nabla raised $24M (Series B) on January 5, 2024.
- Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
- ViaLase raised $45M (Seed) on January 5, 2024.
- OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
Who to call at Alto Neuroscience, and when
A new round usually means Alto Neuroscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alto Neuroscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alto Neuroscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alto Neuroscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alto Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alto Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.